WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.1 Billion CNY | -158.85% |
| 2022 | -1.97 Billion CNY | 58.08% |
| 2021 | -4.7 Billion CNY | -25.09% |
| 2020 | -3.76 Billion CNY | 6.18% |
| 2019 | -4.01 Billion CNY | 1.78% |
| 2018 | -4.08 Billion CNY | -710.59% |
| 2017 | -503.88 Million CNY | -152.47% |
| 2016 | 960.34 Million CNY | 222.66% |
| 2015 | 297.63 Million CNY | 501.73% |
| 2014 | 49.46 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6.99 Billion CNY | 0.0% |
| 2023 Q4 | -5.1 Billion CNY | 0.0% |
| 2023 FY | -5.1 Billion CNY | -158.85% |
| 2023 Q2 | -2.21 Billion CNY | 0.0% |
| 2022 Q2 | -3.73 Billion CNY | 0.0% |
| 2022 Q4 | -1.97 Billion CNY | 0.0% |
| 2022 FY | -1.97 Billion CNY | 58.08% |
| 2021 FY | -4.7 Billion CNY | -25.09% |
| 2021 Q4 | -4.7 Billion CNY | 0.0% |
| 2021 Q2 | -6.68 Billion CNY | 0.0% |
| 2020 Q2 | -29.07 Million CNY | 0.0% |
| 2020 FY | -3.76 Billion CNY | 6.18% |
| 2020 Q4 | -3.76 Billion CNY | 0.0% |
| 2019 Q4 | -4.01 Billion CNY | 0.0% |
| 2019 FY | -4.01 Billion CNY | 1.78% |
| 2019 Q2 | -2.61 Billion CNY | 0.0% |
| 2018 Q4 | -4.08 Billion CNY | 0.0% |
| 2018 Q2 | -4.37 Billion CNY | 0.0% |
| 2018 FY | -4.08 Billion CNY | -710.59% |
| 2017 Q2 | -2.37 Billion CNY | 0.0% |
| 2017 Q4 | -503.88 Million CNY | 0.0% |
| 2017 FY | -503.88 Million CNY | -152.47% |
| 2016 Q4 | 960.34 Million CNY | 0.0% |
| 2016 FY | 960.34 Million CNY | 222.66% |
| 2015 Q2 | 74.4 Million CNY | 0.0% |
| 2015 Q1 | 74.4 Million CNY | 501.73% |
| 2015 Q4 | 74.4 Million CNY | 0.0% |
| 2015 FY | 297.63 Million CNY | 501.73% |
| 2015 Q3 | 74.4 Million CNY | 0.0% |
| 2014 Q3 | 12.36 Million CNY | 0.0% |
| 2014 Q4 | 12.36 Million CNY | 0.0% |
| 2014 FY | 49.46 Million CNY | 0.0% |
| 2014 Q1 | 12.36 Million CNY | 0.0% |
| 2014 Q2 | 12.36 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 442228.422% |
| CSL Limited | 10.52 Billion USD | 148.532% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 32508.044% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 124151.73% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 1271343.676% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 12037.653% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -80928.798% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 551066.041% |
| Mesoblast Limited | 55.85 Million USD | 9245.434% |
| Marizyme, Inc. | 18.56 Million USD | 27610.755% |
| Genus plc | 190.6 Million USD | 2780.21% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 228582.283% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 420936.189% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 751347.059% |
| ContraFect Corporation | -6.02 Million USD | -84673.979% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 3794305.245% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| IMV Inc. | 7.67 Million USD | 66698.866% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 92949.447% |
| MultiCell Technologies, Inc. | 90.04 USD | 5673567403.421% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -695899.063% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 39559.91% |
| EV Biologics, Inc. | 1.36 Million USD | 373534.817% |
| Q BioMed Inc. | 4.06 Million USD | 125924.383% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 16819.513% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 507036.478% |
| Biomind Labs Inc. | 711.4 Thousand USD | 718186.258% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 39989.463% |
| Skye Bioscience, Inc. | -5.72 Million USD | -89187.409% |
| SQZ Biotechnologies Company | -36.23 Million USD | -13997.025% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 3654129.928% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 90541.667% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 227930.025% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 25713494.071% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 820918.685% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 4752.362% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 593942.888% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 232094.736% |
| GB Sciences, Inc. | 1.74 Million USD | 292461.542% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -2779450.351% |
| argenx SE | -2.02 Billion USD | -151.793% |
| HST Global, Inc. | 96.79 Thousand USD | 5277837.026% |
| Halberd Corporation | 144.72 Thousand USD | 3529981.634% |
| Enzolytics Inc. | 981.65 Thousand USD | 520494.11% |
| Resverlogix Corp. | 6.45 Million USD | 79288.963% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -758860.554% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 11861.477% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 8537.388% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | -10766.332% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 255601.673% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 72345.796% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 1420266.245% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 188701.185% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -57688.811% |
| AVAX Technologies, Inc. | -5.9 Million USD | -86437.369% |
| ONE Bio Corp. | 9.04 Million USD | 56609.516% |
| Zenith Capital Corp. | 10.06 Thousand USD | 50760036.407% |
| Genscript Biotech Corporation | -1.06 Billion USD | -381.326% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 2548834.733% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 214199.212% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 3105389.072% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -27887660.673% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 2477335.146% |
| Agentix Corp. | 37.63 Thousand USD | 13575290.667% |
| Adynxx, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -253.1 Thousand USD | -2018248.334% |
| Helix BioMedix, Inc. | -2.57 Million USD | -198671.066% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 25294.713% |
| BioStem Technologies, Inc. | 4.47 Million USD | 114332.277% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 2538424.704% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -389960205.344% |
| LadRx Corporation | -2.03 Million USD | -250749.878% |
| Cell Source, Inc. | 9.23 Million USD | 55434.663% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -25031652.254% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 804373.522% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 804373.522% |
| NovAccess Global Inc. | 2.17 Million USD | 234599.062% |
| Affymax, Inc. | -5.59 Million USD | -91171.753% |
| Itoco Inc. | 228.3 Thousand USD | 2237668.165% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 3756639.132% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 103155.881% |
| CytoDyn Inc. | 20.26 Million USD | 25312.121% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -789564042.195% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -55117429.137% |
| Qrons Inc. | 351.42 Thousand USD | 1453739.02% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 66392.223% |
| SYBLEU INC | 473.71 Thousand USD | 1078489.07% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -2046402.684% |
| Rebus Holdings, Inc. | 305 Thousand USD | 1675011.475% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 114716.441% |
| Mobile Lads Corp. | 484.23 Thousand USD | 1055065.388% |
| International Stem Cell Corporation | 2.59 Million USD | 197338.61% |
| Bioxytran, Inc. | 1.89 Million USD | 269121.135% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 8185061.466% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 234337.242% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 148861.794% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 59827.347% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 661300.326% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -408578.4% |
| Neutra Corp. | 52.18 Thousand USD | 9788897.977% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -205142.266% |
| PureTech Health plc | -167.19 Million USD | -2955.366% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -2085777.146% |
| IXICO plc | -4.44 Million USD | -114837.113% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 38744.981% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 9413.376% |
| CSL Limited | 10.52 Billion USD | 148.532% |
| Cellectis S.A. | -43.81 Million USD | -11558.173% |